Moderna

Ultime notizie

Titoli nella lingua originale della fonte.

• 
  Nvidia, Tesla, Seagate, ON Semi, Strategy, HPE, and More Stocks That Explain Today’s Market (si apre in una nuova scheda)

  Barrons.com · 2 ott 2026

• 
  Warner Bros. Stock Is About to Leave the Nasdaq. Here’s What’s Replacing It. (si apre in una nuova scheda)

  Barrons.com · 2 ott 2026

• 
  Twilio To Join S&P 500 Index (si apre in una nuova scheda)

  Investor's Business Daily · 2 ott 2026

• 
  Nasdaq, S&P 500, Dow Futures Rise Ahead Of Jobs Report: NKE, META, RKLB, MRNA, SLS, TSLA Stocks In Focus (si apre in una nuova scheda)

  Stocktwits · 2 ott 2026

• 
  SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot (si apre in una nuova scheda)

  Stocktwits · 2 ott 2026

• 
  Micron Says Memory Supply Will Be Much Tighter in 2028. Sandisk's Contracts Limit How Much It Can Gain. (si apre in una nuova scheda)

  Motley Fool · 2 ott 2026

• FDA approves Moderna's mRNA seasonal flu vaccine (si apre in una nuova scheda)

  ABC News - Breaking News, Latest News and Videos · 2 ott 2026

• Moderna to replace Warner Bros Discovery on Nasdaq 100 (si apre in una nuova scheda)

  Reuters · 2 ott 2026

• Nasdaq Announces Moderna to Join Nasdaq-100 Index, Replacing Warner Bros. Discovery (si apre in una nuova scheda)

  Quiver Quantitative · 2 ott 2026

• 
  Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 (si apre in una nuova scheda)

  GlobeNewswire · 2 ott 2026

• Northwestern's IP License With Feds Doesn't Protect Moderna (si apre in una nuova scheda)

  Law360 · 1 ott 2026

• Northwestern Wins Bid to Strike Moderna Government Sales Defense (si apre in una nuova scheda)

  Bloomberg Law News · 1 ott 2026

• Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak (si apre in una nuova scheda)

  ABC News - Breaking News, Latest News and Videos · 1 ott 2026

• 
  Moderna (MRNA) Stock Dips While Market Gains: Key Facts (si apre in una nuova scheda)

  Zacks · 1 ott 2026

• 
  Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet (si apre in una nuova scheda)

  StockStory · 1 ott 2026

• Moderna Stock Is Trending: What's Going On? (si apre in una nuova scheda)

  Benzinga · 1 ott 2026

• 
  After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move (si apre in una nuova scheda)

  Investor's Business Daily · 1 ott 2026

• Moderna loses US government license defense in Northwestern patent case (si apre in una nuova scheda)

  Reuters · 1 ott 2026

• 
  Why Citi Is Sounding the Alarm on Moderna Stock (si apre in una nuova scheda)

  Barchart · 1 ott 2026

• 
  Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (si apre in una nuova scheda)

  24/7 Wall St. · 1 ott 2026

• Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (si apre in una nuova scheda)

  24/7 Wall St. · 1 ott 2026

• Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test (si apre in una nuova scheda)

  Simply Wall Street · 1 ott 2026

• The Escalator: Moderna, Hatteras Venture Partners, PhRMA and more (si apre in una nuova scheda)

  Medical Marketing and Media · 1 ott 2026

• Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz (si apre in una nuova scheda)

  1 ott 2026

• Moderna Soars On Cancer Vaccine. Is mRNA Ready For Prime Time? (si apre in una nuova scheda)

  Investor's Business Daily · 1 ott 2026

• Everpure Stock Is September’s Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles In (si apre in una nuova scheda)

  1 ott 2026

• If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's This (si apre in una nuova scheda)

  1 ott 2026

• Moderna, Merck Rally On Cancer Vaccine Promise. But Is The Multi-Billion-Dollar Hype Real? (si apre in una nuova scheda)

  Investor's Business Daily · 1 ott 2026

• Moderna adds COO role as it expands into oncology (si apre in una nuova scheda)

  The Pharma Letter · 1 ott 2026

• Citi delivers major verdict after Moderna’s remarkable 703% run (si apre in una nuova scheda)

  30 set 2026